Navigation Links
Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness
Date:2/13/2009

BOSTON, MA A new national survey conducted by the Harvard Opinion Research Program at the Harvard School of Public Health finds that the vast majority (93%) of Americans have heard or read about the recent ongoing recall of peanut products. Among those who are aware of the recall, about six in ten (61%) say they have taken one or more precautions to reduce their risk of getting sick from contaminated peanut products. Specifically, about one in four say they have checked ingredient lists on foods in the grocery store to make sure they know which products contain peanuts (27%), thrown away foods in their home that they think might be on the recall list (25%), stopped ordering foods containing peanuts in restaurants (22%), and stopped eating those foods they heard were in the recall (28%), while 15% say they have stopped eating all foods containing peanuts.

The poll also finds that among those who are aware of the recall, one in four (25%) mistakenly believe that major national brands of peanut butter are involved in the recall. Seventy percent correctly identify peanut butter crackers as being involved. However, less than half are aware that several other products containing peanuts have been recalled, including some in each of the following food categories: snack bars (49%), cakes, brownies, and cookies (45%), pet treats (43%), candy (39%), pre-packaged meals (36%), ice cream (27%), and jars or cans of dry-roasted peanuts (23%).

The survey was conducted between February 4-8, 2009, during the peanut product recall that began on January 12, 2009.

Links to the survey topline data and charts

"There's a striking level of awareness of this recall, and many people have taken action. But they're not aware of the range of products involved in the recall," said Robert J. Blendon, professor of Health Policy and Political Analysis at the Harvard School of Public Health. "People should check the Food and Drug Administration (FDA)
'/>"/>

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-3952
Harvard School of Public Health
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. TV News Coverage Reports on InnerCools CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago
2. Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period
3. Favrille Announces Name Change to MMR Information Systems, Inc. Following Completion of Merger With MyMedicalRecords, Inc.
4. Following Ceremony with President Obama, UAN President Ann Converso, RN, Commends New Administration on Meeting with Labor Leaders and Reinstating Pro-Worker Policies
5. Pelosi Statement Following House Introduction of SCHIP Legislation
6. LegalView Informs Parents of Crib Recall Following Several Infant Deaths Caused by Asphyxiation from Improper Crib Mechanisms
7. LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
8. Study Finds More Effective Treatment for Pneumonia Following Influenza
9. Study finds more effective treatment for pneumonia following influenza
10. Adding Eccentric Resistance Training Improves Muscle Strength Following ACL Surgery
11. Unique U-M Surgery Creates Fully Usable Tongue Following Tongue Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... discussions with FDA -, MENLO PARK, Calif., Dec. ... of customizable drug-eluting stent (DES),systems, today announced that it ... for CE Mark approval of its Custom NX DES,System., ... dossier and the,drug formulation submission from Biosensors International Group. ...
... ST. PAUL (December 26, 2007) University of Minnesota ... researchers have discovered a new fast-acting antidote to cyanide ... those who are exposed to the chemical namely ... cyanide antidotes work slowly and are ineffective when administered ...
... hay fever and other allergic reactions, by preventing the ... by scientists. Researchers hope their finding, published today (Thursday ... allow therapies to be developed that treat allergies by ... a gene known as GATA-3 can block the development ...
... Dec. 26 A lot of Americans take advantage ... to lose weight and live,healthier. There may be a ... that work focus on healthy long-term lifestyle changes., ... Registered journalists can access video, audio, text, graphics ...
... cell research to needle exchanges to medical marijuana and ... science, according to a new book by a leading ... Weill Cornell Medical College. , "Truth, Lies, and Public ... Collide" (Praeger Press, 2007) is authored by Dr. Madelon ...
... results are promising, they don,t address benefits of drug ... treatment that wipes out abnormal heart tissue reduces the ... implanted after heart attacks, a new trial showed. , ... it slips into abnormal rhythms, they are desirable to ...
Cached Medicine News:Health News:XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe 2Health News:XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe 3Health News:U of M researchers discover fast-acting cyanide antidote 2Health News:Fight against hay fever and other allergies helped by new immune system discovery 2Health News:Heart Procedure Reduces Need for Defibrillator Shocks 2Health News:Heart Procedure Reduces Need for Defibrillator Shocks 3
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/22/2015)... CLEVELAND , Jan. 22, 2015  ViewRay™, a privately ... entered into an exclusive distributor agreement with ITOCHU Corporation ... radiation therapy system for the treatment of cancer in ... (me-rid-i-an) system, is the world,s first and only MRI-guided ...
(Date:1/22/2015)...  Amgen (NASDAQ: AMGN ) today announced that it will ... Tuesday, Jan. 27, 2015, after the close of the U.S. financial ... the investment community at 2 p.m. PT. Participating in the call ... chief executive officer, and other members of Amgen,s senior management team. ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... 8 Group Practice Forum (GPF), an independent network ... Fromer-GPF Patient Journey , a proprietary workflow solution designed ... patient care.  The Journey was developed by the ... FAAFP, who also serves as Assistant Clinical Professor of Family ...
... Protectus Medical Devices, Inc. (OTCQB: PTMD), developer and marketer of innovative safety ... US Patent and Trademark Office on its patent application describing a spring-activated, ... it becoming the gold standard in safety syringe devices.  , ... Dr. John Salstrom , CEO, ...
Cached Medicine Technology:Group Practice Forum Launches Fromer-GPF Patient Journey Providing Physicians with Simple Solutions to Improve Patient Care 2US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others 2US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others 3
Sera available in three levels for the control of accuracy and precision for up to 31 analytes...
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes....
CRP Liquid Conrtols level 3...
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
Medicine Products: